Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
VentriPoint Diagnostics ( (TSE:VPT) ) has shared an announcement.
Ventripoint Diagnostics Ltd. has announced the issuance of 4,015,000 options to its directors, officers, employees, contractors, and consultants, with an exercise price of $0.10 and varying terms. These option grants are part of the company’s strategy to incentivize stakeholders and drive value. Since the last update, 153,200 options were exercised, raising $19,310, and there are currently 11,762,750 options outstanding, with 8,652,750 already vested.
More about VentriPoint Diagnostics
Ventripoint Diagnostics Ltd. is an industry leader in the application of artificial intelligence to echocardiography. The company’s VMS products utilize proprietary KBR technology to provide accurate volumetric cardiac measurements akin to MRI, offering an affordable alternative for cardiologists and enhancing patient care.
YTD Price Performance: -21.74%
Average Trading Volume: 147,422
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$15.41M
For an in-depth examination of VPT stock, go to TipRanks’ Stock Analysis page.
